Aimee E. Houlton - Concepedia

Author

Aimee E. Houlton

University of Birmingham

Also Known As

A E Houlton, A. Houlton, Aimee E Houlton, Aimee E. Houlton, Aimee Houlton

Publications

502

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Cancer Research UK Clinical Trials Unit University of Southampton University of Nottingham University College London

About

Aimee E. Houlton is an author at University of Birmingham specializing in radiation oncology, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	78
2	Medicine	1	1	78
3	Pharmacology	1	1	78
4	Cancer Metabolism	1	1	78
5	Cancer Therapeutics	1	1	78

Aimee E. Houlton

Publications

454

Citations

H-Index

Page 1

	Year	Citations
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide Claire Harrison, Adam J. Mead, Anesh Panchal, Blood	2017	163
Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature Charles Craddock, Aimee E. Houlton, Lynn Quek, Clinical Cancer Research	2017	85
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH) Jennifer Pascoe, Aimee E. Houlton, Charlotte Gaskell, Research Square (Research Square) Cancer ManagementPharmacotherapyBeta-hydroxy Beta-methylbutyrate/arginine/glutamineClinical TrialsCancer Metabolism	2021	78
Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial Kailash Krishnan, S. F. Mukhtar, James Lingard, Journal of Neurology Neurosurgery & Psychiatry	2015	40
Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer San Soo Hoo, Natalie Marriott, Aimee E. Houlton, International Journal of Gynecological Cancer	2015	29
Statistical Analysis Plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) Trial Philip M. Bath, Aimee E. Houlton, Lisa J Woodhouse, International Journal of Stroke	2014	24
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL Toby A. Eyre, Catherine Hildyard, Angela Hamblin, Hematological Oncology	2019	23
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer Jessica Bate, Stephen Baker, Judith Breuer, Archives of Disease in Childhood	2018	12

Page 1